Influence of Microfiltered-seawater Supplementation and Variable Resistance Training in Blood Pressure, Oxidative Stress, Hepatic, and Renal Biomarkers in Older Women
Could Microfiltered-seawater Supplementation and Variable Resistance Training Improve Blood Pressure, Oxidative Stress, Hepatic, and Renal Biomarkers in Older Women? a 32-week, Double-blinded, Randomized, Placebo-controlled Trial
1 other identifier
interventional
109
0 countries
N/A
Brief Summary
This study was conducted to investigate the effects of the intake of deep sea water prior to resistance training on blood pressure, oxidative stress and hepatic and renal variables in older women.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2014
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2015
CompletedFirst Submitted
Initial submission to the registry
September 12, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedSeptember 23, 2024
September 1, 2024
1.2 years
September 12, 2024
September 18, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Malondialdehyde (MDA)
Oxidative stress biomarker
pre (week 0) and post (week 32)
Oxidized/reduced glutathione ratio (GSH/GSSG)
Antioxidant enzyme
pre (week 0) and post (week 32)
Interleukin-6 (IL-6)
Inflammatory biomarker
pre (week 0) and post (week 32)
Vitamin D
Vitamin
pre (week 0) and post (week 32)
Secondary Outcomes (12)
Glutamic-oxaloacetic transaminase (GOT)
pre (week 0) and post (week 32)
Glutamic-pyruvic transaminase (GPT)
pre (week 0) and post (week 32)
Gamma- glutamyl transpeptidase (GGT)
pre (week 0) and post (week 32)
Alkaline phosphatase enzyme (ALP)
pre (week 0) and post (week 32)
Systolic blood pressure (SBP)
pre (week 0) and post (week 32)
- +7 more secondary outcomes
Study Arms (4)
Resistance training + deep sea water
EXPERIMENTALResistance training with elastic bands prior intake of deep sea water (20ml) twice weekly during 32 weeks.
Resistance training + Placebo
ACTIVE COMPARATORResistance training with elastic bands prior placebo water (20ml) twice weekly during 32 weeks.
Control + Deep sea water
ACTIVE COMPARATORNo exercise and intake of deep sea water (20ml) twice weekly during 32 weeks.
Control + Placebo
PLACEBO COMPARATORNo exercise and intake of placebo water (20ml) twice weekly during 32 weeks.
Interventions
A group that will perform a resistance training protocol with variable resistance and at the same time will receive a supplementation composed by deep sea water
A group that will perform a resistance training protocol with variable resistance and at the same time will receive a placebo supplementation that have the same tasted than the deep sea water supplementation
A group that will maintain their usual live and at the same time will receive a supplementation composed by deep sea water
A group that will maintain their usual live and at the same time will receive a placebo supplementation that have the same tasted than the deep sea water supplementation
Eligibility Criteria
You may qualify if:
- (i) women aged ≥65years
- (ii) able to climb 10 stairs without pause and walk 100m without a walker
- (iii) score above 23 points in the mini-mental state examination
- (iv) \<1h of physical activity per week throughout the six months before the study
- (v) possess a medical certificate of aptitude to carry out physical activity
You may not qualify if:
- Participants who had suffered:
- (i) any type of musculoskeletal, cardiovascular, hepatic, renal, pulmonary, neurological, or neuromuscular injury or disorder and/or
- (ii) taking any type of drug/supplement that may alter the results of the study (e.g., vitamin C, vitamin E, estrogens, beta-blockers, calcitonin, steroid hormones, etc.)
- (iii) changes in body weight of more than 10% in the year prior to the study
- (iv) have a severe hearing or visual impairment
- (v) participate in another research project (within the last six months) involving an exercise, dietetic and/or pharmaceutical intervention
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
September 12, 2024
First Posted
September 19, 2024
Study Start
May 1, 2014
Primary Completion
July 1, 2015
Study Completion
July 1, 2015
Last Updated
September 23, 2024
Record last verified: 2024-09